The burden of cancer drugs: Millions battle exorbitant prices as life-saving treatment slips out of reach
For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that remain out of reach, the affordability crisis runs deep. A proposed cap may help, but question remains if it will be enough to change the picture.
Read the full report on The Economic Times
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- The Economic Times
- Reporter
- rica bhattacharyya and vikas dandekar
- Published
- Sunday, 18 October 2026, 9:18 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from The Economic Times with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
